Venlafaxine
Venlafaxine Hydrochloride is a prescription medication that acts as a serotonin and norepinephrine reuptake inhibitor, commonly used to treat depression and anxiety disorders. It is available as generic extended-release oral tablets in 150 mg and 225 mg strengths, manufactured by Dr. Reddy's Laboratories Inc. This information was generated using AI and is provided for informational and research purposes only.
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Venlafaxine Hydrochloride is a prescription medication that acts as a serotonin and norepinephrine reuptake inhibitor, commonly used to treat depression and anxiety disorders. It is available as generic extended-release oral tablets in 150 mg and 225 mg strengths, manufactured by Dr. Reddy's Laboratories Inc. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Venlafaxine",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Venlafaxine — ANDA 214419 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214419"
}
]
|
| identifier | ANDA214419 |
| issued | 2016-09-16 |
| keyword |
[
"drug-information",
"drug-safety",
"health-care",
"pharmaceuticals",
"public-health"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Venlafaxine |
